MedTrace Logo

Study to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children

NCT00403819 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-11-28

No results posted yet for this study

Summary

A phase III, multi-centre, double blind, placebo controlled, crossover study, followed by an open label post study follow-up, to assess the efficacy and safety of Movicol in the treatment of chronic constipation in children

Conditions

  • Chronic Constipation

Interventions

DRUG

Polyethylene glycol 3350 Na bicarbonate NaCl KCl (Movicol)

Sponsors & Collaborators

Principal Investigators

  • Michael A Thomson, MD · Royal Free Hospital NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
24 Months
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Completion
2003-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00403819 on ClinicalTrials.gov